The wellness industry is strongly focused on biological “clocks.” These tools estimate how old you are biologically—not in calendar years, but in terms of your body’s actual health—by analyzing samples such as blood, saliva, or cheek cells. Lifestyle Changes Linked to a Younger Biological Age Research into biological clocks suggests that a broad range of […]
Biological clocks uncover hidden drivers that accelerate aging Read More »
Inflammatory bowel disease (IBD) is a painful condition affecting the digestive system. Scientists have spent decades trying to understand its underlying causes in order to improve treatments for these chronic and often debilitating disorders. A recent study now marks a major breakthrough. Researchers from the UK and Denmark have resolved a 30-year-old question: why is
Scientists unravel a 30-year-old mystery behind inflammatory bowel disease Read More »
A child’s small, pale, chalk-white baby teeth fall out and are replaced by yellow-brown, fragile teeth, often catching parents by surprise. This dental condition, known as molar incisor hypomineralisation (MIH), is nearly as common as tooth decay, yet it remains largely unfamiliar outside dentistry and is sometimes misdiagnosed even by professionals. MIH affects the development
A little-known dental condition could be impacting millions of children Read More »
The U.S. The FDA has expanded approval of Tzield (teplizumab), making it the first disease-modifying therapy for children and adolescents newly diagnosed with stage 3 type 1 diabetes. They made the announcement on Monday, June 15. The updated authorization covers patients aged 8 to 17 who have recently received a diagnosis. Rather than replacing insulin
US approves first drug that slows type 1 diabetes progression Read More »
Scientists at Japan’s Shibaura Institute of Technology developed vitamin K–based compounds that are up to three times more effective at converting neural stem cells into mature neurons, potentially enabling regenerative treatments for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s. Phylloquinone (vitamin K1) and menaquinones (vitamin K2, such as MK-4 and MK-7) are best described
Japanese researchers developed an enhanced vitamin K that helps repair damaged neurons Read More »
A Chilean researcher has developed a probiotic that inhibits the growth of the cancer-associated bacterium Helicobacter pylori in the stomach while also supporting a healthy balance of intestinal bacteria. The findings were published in the Electronic Journal of Biotechnology. 17-Year Study Yields Probiotic Against H. pylori After 17 years of research, scientists have transformed the
Chilean scientist finds probiotic that blocks cancer-causing stomach bacteria Read More »
Swiss scientists have created a novel blood-filtering device that removes the toxic proteins linked to Alzheimer’s disease—beta-amyloid and tau—from the bloodstream. These proteins build up in the brain and contribute to cognitive decline, but early clinical studies suggest that reducing their levels can improve memory and thinking abilities within weeks. Nanofilter Technology Targets Existing Alzheimer’s
Blood nanofilter removes Alzheimer’s proteins in hours, potentially reversing dementia Read More »
A new universal coronavirus vaccine has completed its first human clinical trial, representing a key advance toward broader protection against future outbreaks. Researchers at the University of Cambridge and the spinout company DIOSynVax (DVX) Ltd developed the experimental vaccine and tested it on 39 healthy volunteers, finding it to be safe with no serious side
An AI-designed universal coronavirus vaccine has passed its first human trial Read More »
Scientists in Sweden have developed a more reliable way to produce insulin-producing cells from human stem cells, a potential advance for type 1 diabetes treatment. Published in Stem Cell Reports, the cells regulated blood sugar and reversed diabetes in mice. Type 1 diabetes occurs when the immune system mistakenly destroys the pancreatic cells responsible for
Researchers reversed diabetes in mice using lab-grown insulin cells Read More »
An international study suggests that many women with early-stage breast cancer can safely skip chemotherapy without affecting their chances of successful treatment. The findings come from the OPTIMA clinical trial, which tested whether a genomic test could identify patients who truly benefit from chemotherapy. The study included over 4,400 participants aged 40 and above from
Genetic testing may help some breast cancer patients avoid chemotherapy, a study finds Read More »
